Literature DB >> 3381104

Prognostic implications of the International Staging System for Lung Cancer.

C F Mountain1.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3381104

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  10 in total

1.  Radiologic staging of lung carcinoma: a report generator and database system.

Authors:  M G Dunne; S B Dunne
Journal:  J Digit Imaging       Date:  1989-02       Impact factor: 4.056

2.  Inhibition of non-small-cell lung cancer cell proliferation by Pbx1.

Authors:  Weihao Li; Kai Huang; Haizhou Guo; Guanghui Cui; Song Zhao
Journal:  Chin J Cancer Res       Date:  2014-10       Impact factor: 5.087

3.  [Lung cancer--hopelessness in inoperability? A 10-year follow-up].

Authors:  N Schwegler
Journal:  Strahlenther Onkol       Date:  1997-07       Impact factor: 3.621

Review 4.  Extended resection for higher-stage non-small-cell lung cancer.

Authors:  J D Luketich; D E van Raemdonck; R J Ginsberg
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

5.  Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.

Authors:  Nicholas W Choong; Everett E Vokes; Daniel J Haraf; Peter K Tothy; Mark K Ferguson; Kristen Kasza; Charles M Rudin; Philip C Hoffman; Stuart A Krauss; Livia Szeto; Ann M Mauer
Journal:  J Thorac Oncol       Date:  2008-01       Impact factor: 15.609

6.  Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial.

Authors:  Kathy S Albain; R Suzanne Swann; Valerie W Rusch; Andrew T Turrisi; Frances A Shepherd; Colum Smith; Yuhchyau Chen; Robert B Livingston; Richard H Feins; David R Gandara; Willard A Fry; Gail Darling; David H Johnson; Mark R Green; Robert C Miller; Joanne Ley; Willliam T Sause; James D Cox
Journal:  Lancet       Date:  2009-07-24       Impact factor: 79.321

7.  Loss of blood group antigen A in non-small cell lung cancer.

Authors:  J L Gwin; A J Klein-Szanto; S Y Zhang; P Agarwal; A Rogatko; S M Keller
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

8.  Survival from lung cancer in England and Wales up to 2001.

Authors:  Y K Zee; T Eisen
Journal:  Br J Cancer       Date:  2008-09-23       Impact factor: 7.640

9.  Preoperative concurrent chemoradiotherapy with cisplatin and docetaxel in patients with locally advanced non-small-cell lung cancer.

Authors:  H Katayama; H Ueoka; K Kiura; M Tabata; T Kozuki; M Tanimoto; T Fujiwara; N Tanaka; H Date; M Aoe; N Shimizu; M Takemoto; Y Hiraki
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

10.  DNA ploidy and proliferative activity in bcl-2 expressed non-small cell lung cancer.

Authors:  Y C Kim; K O Park; H J Kim; I S Choi; C S Park; S W Juhng
Journal:  Korean J Intern Med       Date:  1996-06       Impact factor: 2.884
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.